These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37759969)

  • 1. First Generation of Antioxidant Precursors for Bioisosteric Se-NSAIDs: Design, Synthesis, and In Vitro and In Vivo Anticancer Evaluation.
    Ramos-Inza S; Aliaga C; Encío I; Raza A; Sharma AK; Aydillo C; Martínez-Sáez N; Sanmartín C; Plano D
    Antioxidants (Basel); 2023 Aug; 12(9):. PubMed ID: 37759969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and anticancer evaluation of novel Se-NSAID hybrid molecules: Identification of a Se-indomethacin analog as a potential therapeutic for breast cancer.
    Ramos-Inza S; Encío I; Raza A; Sharma AK; Sanmartín C; Plano D
    Eur J Med Chem; 2022 Dec; 244():114839. PubMed ID: 36257283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling a New Selenocyanate as a Multitarget Candidate with Anticancer, Antileishmanial and Antibacterial Potential.
    Ramos-Inza S; Henriquez-Figuereo A; Moreno E; Berzosa M; Encío I; Plano D; Sanmartín C
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Acylselenourea Derivatives: Dual Molecules with Anticancer and Radical Scavenging Activity.
    Astrain-Redin N; Raza A; Encío I; Sharma AK; Plano D; Sanmartín C
    Antioxidants (Basel); 2023 Jun; 12(7):. PubMed ID: 37507871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New organoselenides (NSAIDs-Se derivatives) as potential anticancer agents: Synthesis, biological evaluation and in silico calculations.
    He X; Nie Y; Zhong M; Li S; Li X; Guo Y; Liu Z; Gao Y; Ding F; Wen D; Zhang Y
    Eur J Med Chem; 2021 Jun; 218():113384. PubMed ID: 33799070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit DNA synthesis and the growth of colon cancer cells in vitro.
    Dial EJ; Doyen JR; Lichtenberger LM
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):295-300. PubMed ID: 16032431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antioxidant and antiproliferative activities of selenium-containing phycocyanin from selenium-enriched Spirulina platensis.
    Chen T; Wong YS
    J Agric Food Chem; 2008 Jun; 56(12):4352-8. PubMed ID: 18522403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and Evaluation of Novel Indole Hybrid Chalcones and Their Antiproliferative and Antioxidant Activity.
    Kudličková Z; Michalková R; Salayová A; Ksiažek M; Vilková M; Bekešová S; Mojžiš J
    Molecules; 2023 Sep; 28(18):. PubMed ID: 37764359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Organoselenium (NSAIDs-Selenourea and Isoselenocyanate) Derivatives as Potential Antiproliferative Agents: Synthesis, Biological Evaluation and in Silico Calculations.
    Nie Y; Li S; Lu Y; Zhong M; Li X; Zhang Y; He X
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, and Biological Evaluation of Novel Selenium (Se-NSAID) Molecules as Anticancer Agents.
    Plano D; Karelia DN; Pandey MK; Spallholz JE; Amin S; Sharma AK
    J Med Chem; 2016 Mar; 59(5):1946-59. PubMed ID: 26750401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of organoselenium (NSAIDs-SeCN and SeCF
    He X; Zhong M; Li S; Li X; Li Y; Li Z; Gao Y; Ding F; Wen D; Lei Y; Zhang Y
    Eur J Med Chem; 2020 Dec; 208():112864. PubMed ID: 32987314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
    Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
    Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-proliferative, apoptotic potential of synthesized selenium nanoparticles against breast cancer cell line (MCF7).
    Soltani L; Darbemamieh M
    Nucleosides Nucleotides Nucleic Acids; 2021; 40(9):926-941. PubMed ID: 34396908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of Novel Erlotinib-NSAID Conjugates as More Comprehensive Anticancer Agents.
    Zhang Y; Tortorella MD; Liao J; Qin X; Chen T; Luo J; Guan J; Talley JJ; Tu Z
    ACS Med Chem Lett; 2015 Oct; 6(10):1086-90. PubMed ID: 26487917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
    Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
    Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selenium Ameliorates Ibuprofen Induced Testicular Toxicity by Redox Regulation: Running Head: Se protects against NSAID induced testicular toxicity.
    Sharma P; Kaur P; Ghanghas P; Kaur J; Kaushal N
    Reprod Toxicol; 2020 Sep; 96():349-358. PubMed ID: 32800787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seleno-Analogs of Scaffolds Resembling Natural Products a Novel Warhead toward Dual Compounds.
    Astrain-Redin N; Talavera I; Moreno E; Ramírez MJ; Martínez-Sáez N; Encío I; Sharma AK; Sanmartín C; Plano D
    Antioxidants (Basel); 2023 Jan; 12(1):. PubMed ID: 36671001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.
    Liu QQ; Lu K; Zhu HM; Kong SL; Yuan JM; Zhang GH; Chen NY; Gu CX; Pan CX; Mo DL; Su GF
    Eur J Med Chem; 2019 Mar; 165():293-308. PubMed ID: 30685528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer activity, dual prooxidant/antioxidant effect and apoptosis induction profile of new bichalcophene-5-carboxamidines.
    Ismail MA; Negm A; Arafa RK; Abdel-Latif E; El-Sayed WM
    Eur J Med Chem; 2019 May; 169():76-88. PubMed ID: 30856408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.